Lexicon Pharmaceuticals, Inc. Profile Avatar - Palmy Investing

Lexicon Pharmaceuticals, Inc.

Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that complet…

Biotechnology
US, The Woodlands [HQ]
Similar Stocks · Benchmarked Analysis · Peer Group

Peers Performance

A quick analysis that compared Lexicon Pharmaceuticals, Inc. (LXRX) to it's peer group.

Peer Group
Loading...
End of LXRX's Analysis
CIK: 1062822 CUSIP: 528872302 ISIN: US5288723027 LEI: - UEI: -
Secondary Listings
LXRX has no secondary listings inside our databases.